South Korea
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 658.71 M
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
2 |
USD 411.38 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
3 |
USD 163.22 M
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
4 |
USD 117.25 M
|
Dec. 31, 2023 | USD 13.69 | -2.57% |
|
South Korea |
|
5 |
USD 112.31 M
|
Dec. 31, 2023 | USD 159.35 | -4.24% |
|
South Korea |
|
6 |
USD 88.41 M
|
Dec. 31, 2023 | USD 18.22 | -3.57% |
|
South Korea |
|
7 |
USD 85.63 M
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
8 |
USD 71.82 M
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
9 |
USD 44.54 M
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
10 |
USD 39.73 M
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
11 |
USD 37.14 M
|
Dec. 31, 2023 | USD 15.36 | -2.10% |
|
South Korea |
|
12 |
USD 36.23 M
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
13 |
USD 36.10 M
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
14 |
USD 30.88 M
|
Dec. 31, 2023 | USD 6.82 | -1.91% |
|
South Korea |
|
15 |
USD 29.48 M
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
16 |
USD 28.42 M
|
Dec. 31, 2023 | USD 15.49 | -2.92% |
|
South Korea |
|
17 |
USD 28.39 M
|
Dec. 31, 2023 | USD 3.69 | -1.06% |
|
South Korea |
|
18 |
USD 28.20 M
|
Dec. 31, 2023 | USD 16.51 | 0.47% |
|
South Korea |
|
19 |
USD 22.87 M
|
Dec. 31, 2023 | USD 7.90 | -1.67% |
|
South Korea |
|
20 |
USD 21.07 M
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
21 |
USD 19.93 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
22 |
USD 18.37 M
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
23 |
USD 17.14 M
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
24 |
USD 16.33 M
|
Dec. 31, 2023 | USD 34.59 | -4.65% |
|
South Korea |
|
25 |
USD 15.04 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
26 |
USD 14.52 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
27 |
USD 11.62 M
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
28 |
USD 10.73 M
|
Dec. 31, 2023 | USD 4.14 | -7.03% |
|
South Korea |
|
29 |
USD 8.85 M
|
Dec. 31, 2023 | USD 7.33 | -4.07% |
|
South Korea |
|
30 |
USD 8.54 M
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
31 |
USD 7.49 M
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
32 |
USD 7.09 M
|
Dec. 31, 2023 | USD 9.81 | -0.42% |
|
South Korea |
|
33 |
USD 5.58 M
|
Dec. 31, 2023 | USD 1.89 | -1.74% |
|
South Korea |
|
34 |
USD 4.96 M
|
Dec. 31, 2023 | USD 1.18 | -3.42% |
|
South Korea |
|
35 |
USD 4.40 M
|
Dec. 31, 2023 | USD 2.87 | -2.35% |
|
South Korea |
|
36 |
USD 2.75 M
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
37 |
USD 2.75 M
|
Dec. 31, 2023 | USD 5.00 | -8.15% |
|
South Korea |
|
38 |
USD 2.54 M
|
Dec. 31, 2023 | USD 11.86 | -0.20% |
|
South Korea |
|
39 |
USD 2.02 M
|
Dec. 31, 2023 | USD 3.22 | 0.07% |
|
South Korea |
|
40 |
USD 1.28 M
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
41 |
USD 513.80 K
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
42 |
USD -2.03 M
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
|
43 |
USD -2.18 M
|
Dec. 31, 2023 | USD 11.83 | -21.52% |
|
South Korea |
|
44 |
USD -2.59 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
45 |
USD -2.98 M
|
Dec. 31, 2023 | USD 1.37 | -0.64% |
|
South Korea |
|
46 |
USD -3.48 M
|
Dec. 31, 2023 | USD 1.12 | -3.94% |
|
South Korea |
|
47 |
USD -4.60 M
|
Dec. 31, 2023 | USD 7.21 | -0.62% |
|
South Korea |
|
48 |
USD -5.51 M
|
Dec. 31, 2023 | USD 3.01 | -3.95% |
|
South Korea |
|
49 |
USD -6.46 M
|
Dec. 31, 2023 | USD 3.25 | -3.09% |
|
South Korea |
|
50 |
USD -7.16 M
|
Dec. 31, 2023 | USD 1.01 | -3.22% |
|
South Korea |
The Healthcare company in South Korea with the highest Net Income is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 658.71 M.
The Healthcare company in South Korea with the lowest Net Income is SD BioSensor, Inc (KSE: 137310.KS) at USD -359.20 M.
The top 10 Healthcare companies in South Korea by Net Income are Samsung Biologics Co.,Ltd., Celltrion, Inc., Chong Kun Dang Pharmaceutical Corp., Daewoong Co., Ltd., Hanmi Pharm. Co., Ltd., Hanmi Science Co., Ltd., Daewoong pharmaceutical Co.,Ltd, Yuhan Corporation, Dong-A Socio Holdings Co., Ltd. and Value Added Technology Co., Ltd..
The bottom 10 Healthcare companies in South Korea by Net Income are SD BioSensor, Inc, Aprogen pharmaceuticals,Inc., GeneOne Life Science, Inc., Genexine, Inc., Helixmith Co., Ltd, EOFLOW Co.,Ltd., Shin Poong Pharm.Co.,Ltd., Green Cross Holdings Corporation, CrystalGenomics, Inc. and MedPacto, Inc..